Logo of Bubs Australia (ASX:BUB)Latest Bubs Australia (ASX:BUB) News

Page 2
Page 2 of 2

Bubs Australia’s FY25 Profit Surges 124% Amid FDA Approval Hopes

Bubs Australia Limited reports a striking turnaround in FY25 with revenue up 29% to $102.5 million and net profit soaring 124% to $5.17 million, driven by strong US and China growth. The company awaits permanent FDA approval, a pivotal factor for its future trajectory.
Victor Sage
29 Aug 2025

Bubs Australia Taps Joe Coote to Drive Global Infant Nutrition Expansion

Bubs Australia has appointed Joe Coote as its new CEO, bringing extensive international FMCG and dairy leadership to spearhead its global growth ambitions in infant nutrition.
Victor Sage
28 July 2025

Bubs Australia Posts 29% Revenue Surge and Returns to Profitability in FY25

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.
Victor Sage
28 July 2025

Bubs Advances US Market Bid with Landmark Infant Formula Submission

Bubs Australia has submitted critical clinical trial data to the US FDA, marking a pivotal step toward permanent approval for its infant formulas in the US market.
Victor Sage
16 June 2025

Bubs Secures $26.5M Arbitration Win Over Alpha Group Subsidiaries

Bubs Australia has triumphed in a long-standing legal dispute, winning $26.5 million in arbitration awards against Alpha Group subsidiaries Alice Trading and Willis Trading. The company now faces the challenge of recovering the awarded sums.
Victor Sage
29 Apr 2025

Bubs Australia Posts $2.9m EBITDA Turnaround, Eyes FDA Approval in 2025

Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.
Eva Park
22 Jan 2025